0 projects

IS-BILAT-Mobilitet Norge-USA /Canada

Gonadal function in survivor's after malignant lymphoma.

During the 1980-ies oncologists have become aware of the clinical significance of post-treatment gonadal function in long-term cancer survivors. Therefore, fertility-saving treatment regimens have been developed in particular for good-prognosis lymphoma p atients, including the use of less gonado...

Awarded: NOK 0.16 mill.

Project Period: 2008-2008

Location: Ukjent Fylke

IS-BILAT-Mobilitet Norge-USA /Canada

Studies of B cell lymphomas at the single cell level

In the research group of Prof. Erlend Smeland, where I have been working for several years, we are working with normal and malignant B cells to identify genes or aberrant signaling pathways that are of importance for the pathogenesis of lymphoma. Prof. Ro nald Levy at Stanford University School o...

Awarded: NOK 0.28 mill.

Project Period: 2008-2008

Location: Ukjent Fylke

NANOMAT-Nanoteknologi og nye materialer

Entry of Nanoparticles into cells: Characterization of Nanoparticles as tools to study endocytic pathways and intracellular transport

Research on nanoparticles have evolved into biological applications with large expectations for the use of magnetic iron oxide nanoparticles and fluorescent Quantum dots in different imaging techniques both for tumor targeting and drug delivery in humans and as probes at the cellular level. In th...

Awarded: NOK 3.4 mill.

Project Period: 2006-2011

Location: Ukjent Fylke

FUGE-Funksjonell genomforskn.i Norg

Entry of Nanoparticles into cells: Characterization of Nanoparticles as tools to study endocytic pathways..

...

Awarded: NOK 2.7 mill.

Project Period: 2006-2010

Location: Ukjent Fylke

GNBIO-Grunnleggende næringsrettet bioteknologi

Selection and characterization of novel cancer specific antibodies – utilization in diagnostic and therapeutic approaches

Objective: The main purpose is to identify and characterize novel breast cancer specific antibodies. Interesting candidates will be thoroughly characterized for their specificity. Fulfilling the specificity criteria their potential as diagnostic or progno stic markers will be investigated. Finall...

Awarded: NOK 4.0 mill.

Project Period: 2005-2010

Location: Ukjent Fylke

FUGE-Funksjonell genomforskn.i Norg

Regulation and molecular functions of replication proteins

...

Awarded: NOK 14.0 mill.

Project Period: 2004-2009

Location: Ukjent Fylke

FUGE-Funksjonell genomforskn.i Norg

Mutant p53 as a target for improved cancer treatment

This project is a multi-disciplinary approach to explore and exploit the contribution of mutp53 to cancer. We will investigate in depth the molecular properties of mutp53: structural studies will pinpoint the changes that particular mutations inflict on t he structure of p53, and allow the classi...

Awarded: NOK 0.59 mill.

Project Period: 2004-2004

Location: Ukjent Fylke

FUGE-Funksjonell genomforskn.i Norg

Integral approach to characterise clinically and therapeutically relevant biological pathways in human cancer

The time after the sequencing of the human genome, often referred to as the post-Genome era, is characterised by an increased scale of biological analysis at the genome, transcriptome and proteome levels. The final goal of this huge parallel analysis is to study the structure and expression of t...

Awarded: NOK 8.9 mill.

Project Period: 2002-2008

Location: Ukjent Fylke

FUGE-Funksjonell genomforskn.i Norg

Genome wide studies of breast cancer: A bioinf. and genetic appr. to understand gene reg. and dysreg. in breast tumor development and progr.

The fundamental defects in cancer are alterations in the genome. Microarray-based Comparative Genome Hybridization (array CGH) provides the possibility to connect DNA copy-aberrations with genomic map positions. In a first attempt to compare data from di fferent types of CGH techniques, samples ...

Awarded: NOK 2.3 mill.

Project Period: 2002-2006

Location: Ukjent Fylke

FARM-Farmakologisk, farmasøytisk forskning

The biophysical features of protoporphyrin IX induced by aminolevulinic acid and its ester derivatives in vivo

...

Awarded: NOK 0.30 mill.

Project Period: 2002-2004

Location: Ukjent Fylke

MHGRUPP2-MH-grupper

Protein-membrane dynamics in intracellular transport

...

Awarded: NOK 13.0 mill.

Project Period: 2001-2005

Location: Ukjent Fylke